Ketoconazole (all routes except local only)

Exposed non-exposed, cohort studies

Study Country
Study period
Study design
Data source Exposure definition Non-exposure definition Exposition period Sample size
(exposed/unexposed) Or (case / control)
Remarks Risk of bias
Molgaard-Nielsen
2013
Denmark
1996 - 2011
population based cohort retrospective
Registry-based cohort of liveborn infants in Denmark Women who fill prescriptions for oral ketoconazole agents during the first trimester. unexposed (general population or NOS)
Women who did not fill prescriptions for oral azole antifungal agents during the first trimester.
1st trimester 72 / 968236 Oral exposure.
Prescriptions for oral fluconazole that were filled by the women during pregnancy was obtained from the National Prescription Registry.

Case-control studies

Study Country
Study period
Study design
Data source Case Control Exposition Exposition period Sample size
(exposed/unexposed) Or (case / control)
Remarks Risk of bias
Carter
2008
USA
1997 - 2003
case control
National Birth Defects Prevention Study (NBDPS), USA Cases with selected birth defects (included live births, stillbirths 20 weeks or longer or greater than 500 g, or elective terminations). Live births without birth defects that were randomly selected from birth certificates or birth hospitals in the geographic regions monitored by the state surveillance systems. Structured maternal interviews were conducted mainly by telephone in English or Spanish no later than 24 months after the expected date of delivery (EDD) to obtain data on maternal exposures during pregnancy. 1st trimester 12274 / 4774
Cases and controls were identified by the birth defects surveillance systems in 10 states of USA. Medical records were obtained for all cases and reviewed by clinical geneticists.
Kazy
2005
Hungary
1980 - 1996
case control
Hungarian Case-Control Surveillance of Congenital Abnormalities (HCCSCA) Cases with isolated and multiple congenital anomalies selected from the Hungarian Congenital Abnormality Registry. Newborn infants without congenital abnormality. The exposure data were obtained prospectively through antenatal care logbooks and other medical records, and retrospectively through questionnaires completed by the infants’ mothers. 1st trimester 22843 / 38151 Oral ketoconazole exposure.
The Hungarian Congenital Abnormality Registry (HCAR), in which notification by physicians of cases with Congenital anomalies is mandatory. Controls were selected from the National Birth Registry of the Central Statistical Office.

Risk of bias: : NA;   : low;   : moderate;   : serious;   : critical;   : unclear;  

master protocol